In another study, cystinosis patients with advanced CKD exhibited suppressed FGF23 levels, alongside high levels of bone turnover markers, highlighting a distinct mineral imbalance different from other forms of CKD and underscoring the need for cystinosis-specific management strategies [36]. The gene discussed is FGF23; the disease is cystinosis.